Growth Metrics

Sonoma Pharmaceuticals (SNOA) Shares Repurchased (2018 - 2022)

Sonoma Pharmaceuticals has reported Shares Repurchased over the past 5 years, most recently at $9000.0 for Q4 2022.

  • For Q4 2022, Shares Repurchased changed N/A year-over-year to $9000.0; the TTM value through Dec 2022 reached $20000.0, changed N/A, while the annual FY2021 figure was $39000.0, 2.63% up from the prior year.
  • Shares Repurchased for Q4 2022 was $9000.0 at Sonoma Pharmaceuticals, up from $5000.0 in the prior quarter.
  • Over five years, Shares Repurchased peaked at $45000.0 in Q2 2018 and troughed at $3000.0 in Q2 2021.
  • A 5-year average of $14222.2 and a median of $9000.0 in 2019 define the central range for Shares Repurchased.
  • Biggest five-year swings in Shares Repurchased: tumbled 83.33% in 2021 and later surged 66.67% in 2022.
  • Year by year, Shares Repurchased stood at $16000.0 in 2018, then plummeted by 43.75% to $9000.0 in 2019, then surged by 100.0% to $18000.0 in 2020, then tumbled by 83.33% to $3000.0 in 2021, then surged by 200.0% to $9000.0 in 2022.
  • Business Quant data shows Shares Repurchased for SNOA at $9000.0 in Q4 2022, $5000.0 in Q3 2022, and $3000.0 in Q3 2021.